Islet amyloid polypeptide inhibits glucagon release and exerts a dual action on insulin release from isolated islets.
Författare
Summary, in English
We have studied the influence of a wide concentration range of islet amyloid polypeptide (IAPP) on both glucagon and insulin release stimulated by various types of secretagogues. In an islet incubation medium devoid of glucose, the rate of glucagon release being high, we observed a marked suppressive action by low concentrations of IAPP, 10−10 and 10−8 M, on glucagon release. Similarly, glucagon release stimulated by Image-arginine, the cholinergic agonist carbachol, or the phosphodiesterase inhibitor isobutylmethyl xanthine (IBMX), an activator of the cyclic AMP system, was inhibited by IAPP in the 10−10 and 10−8 M concentration range. Moreover, basal glucagon release at 7 and 10 mM glucose was suppressed by IAPP. In contrast, IAPP exerted a dual action on insulin release. Hence, low concentrations of IAPP brought about a modest increase of basal insulin secretion at 7 mM glucose and also of insulin release stimulated by carbachol. High concentrations of IAPP, however, inhibited insulin release stimulated by glucose (10 and 16.7 mM), IBMX, carbachol and Image-arginine. In conclusion, our data suggest that IAPP has complex effects on islet hormone secretion serving as an inhibitor of glucagon release and having a dual action on insulin secretion exerting mainly a negative feedback on stimulated and a positive feedback on basal insulin release.
Avdelning/ar
Publiceringsår
2003
Språk
Engelska
Sidor
55-60
Publikation/Tidskrift/Serie
Regulatory Peptides
Volym
111
Issue
1-3
Länkar
Dokumenttyp
Artikel i tidskrift
Förlag
Elsevier
Ämne
- Cell and Molecular Biology
Nyckelord
- Phosphodiesterase inhibition
- Image-Arginine
- slet secretory mechanisms
- Glucose
- Cholinergic agonist
Status
Published
Forskningsgrupp
- Family Medicine and Clinical Epidemiology
ISBN/ISSN/Övrigt
- ISSN: 1873-1686